# Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease

> **NCT04976816** · PHASE2,PHASE3 · COMPLETED · sponsor: **Assiut University** · enrollment: 92 (actual)

## Conditions studied

- Thyroid Eye Disease

## Interventions

- **PROCEDURE:** peri-levator betamethasone injection
- **PROCEDURE:** peri-levator triamcinolone injection
- **PROCEDURE:** peri-levator and retrobulbar betamethasone injection
- **PROCEDURE:** peri-levator and retrobulbar triamcinolone injection

## Key facts

- **NCT ID:** NCT04976816
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04976816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04976816, "Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04976816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*